Patents by Inventor Michael David Schuster

Michael David Schuster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230346846
    Abstract: A method for preventing the development of or treating GvHD complications in a mammalian patient which comprises administering to the mammal a population of cells enriched for STRO-1bright cells and/or progeny thereof and/or soluble factors derived therefrom.
    Type: Application
    Filed: March 29, 2023
    Publication date: November 2, 2023
    Applicant: Mesoblast Inc.
    Inventors: Silviu Itescu, Michael David Schuster
  • Publication number: 20210085723
    Abstract: A method for preventing the development of or treating GvHD complications in a mammalian patient which comprises administering to the mammal a population of cells enriched for STRO-1bright cells and/or progeny thereof and/or soluble factors derived therefrom.
    Type: Application
    Filed: October 22, 2020
    Publication date: March 25, 2021
    Applicant: Mesoblast, Inc.
    Inventors: Silviu Itescu, Michael David Schuster
  • Patent number: 10849932
    Abstract: A method for preventing the development of or treating GvHD complications in a mammalian patient which comprises administering to the mammal a population of cells enriched for STRO-1bright cells and/or progeny thereof and/or soluble factors derived therefrom.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: December 1, 2020
    Assignee: MESOBLAST, INC.
    Inventors: Silviu Itescu, Michael David Schuster
  • Publication number: 20190030080
    Abstract: A method for preventing the development of or treating GvHD complications in a mammalian patient which comprises administering to the mammal a population of cells enriched for STRO-1bright cells and/or progeny thereof and/or soluble factors derived therefrom.
    Type: Application
    Filed: September 14, 2018
    Publication date: January 31, 2019
    Applicant: Mesoblast, Inc.
    Inventors: Silviu Itescu, Michael David Schuster
  • Patent number: 10105394
    Abstract: A method for preventing the development of or treating GvHD complications in a mammalian patient which comprises administering to the mammal a population of cells enriched for STRO-1bright cells and/or progeny thereof and/or soluble factors derived therefrom.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: October 23, 2018
    Assignee: MESOBLAST, INC.
    Inventors: Silviu Itescu, Michael David Schuster
  • Publication number: 20170258846
    Abstract: A method for suppressing T cell activation which comprises contacting a cell population comprising T cells in vitro or ex vivo with an effective amount of STRO-1+ cells and/or soluble factors derived therefrom to suppress T cell activation.
    Type: Application
    Filed: May 15, 2017
    Publication date: September 14, 2017
    Applicant: Mesoblast, Inc.
    Inventors: Silviu Itescu, Michael David Schuster
  • Publication number: 20160361363
    Abstract: A method for preventing the development of or treating GvHD complications in a mammalian patient which comprises administering to the mammal a population of cells enriched for STRO-1bright cells and/or progeny thereof and/or soluble factors derived therefrom.
    Type: Application
    Filed: February 26, 2016
    Publication date: December 15, 2016
    Applicant: Mesoblast, Inc.
    Inventors: Silviu Itescu, Michael David Schuster
  • Patent number: 9415072
    Abstract: The present invention relates to a method of transplanting haematopoietic precursor cells into a subject in need thereof which involves culturing the haematopoietic precursor cells in the presence of a population of cells enriched for STRO-1bright cells. The method of the present invention is useful in the treatment of haematological disorders.
    Type: Grant
    Filed: September 3, 2014
    Date of Patent: August 16, 2016
    Assignee: MESOBLAST, INC.
    Inventors: Silviu Itescu, Michael David Schuster
  • Patent number: 9301978
    Abstract: A method for preventing the development of or treating GvHD complications in a mammalian patient which comprises administering to the mammal a population of cells enriched for STRO-1bright cells and/or progeny thereof and/or soluble factors derived therefrom.
    Type: Grant
    Filed: July 4, 2011
    Date of Patent: April 5, 2016
    Assignee: MESOBLAST, INC.
    Inventors: Silviu Itescu, Michael David Schuster
  • Publication number: 20150202232
    Abstract: The present invention relates to a method of transplanting haematopoietic precursor cells into a subject in need thereof which involves culturing the haematopoietic precursor cells in the presence of a population of cells enriched for STRO-1bright cells. The method of the present invention is useful in the treatment of haematological disorders.
    Type: Application
    Filed: September 3, 2014
    Publication date: July 23, 2015
    Applicant: MESOBLAST, INC.
    Inventors: Silviu Itescu, Michael David Schuster
  • Patent number: 8828375
    Abstract: The present invention relates to a method of transplanting haematopoietic precursor cells into a subject in need thereof which involves culturing the haematopoietic precursor cells in the presence of a population of cells enriched for STRO-1bright cells. The method of the present invention is useful in the treatment of haematological disorders.
    Type: Grant
    Filed: September 3, 2009
    Date of Patent: September 9, 2014
    Assignee: Mesoblast, Inc.
    Inventors: Silviu Itescu, Michael David Schuster
  • Publication number: 20130171113
    Abstract: A method for preventing the development of or treating GvHD complications in a mammalian patient which comprises administering to the mammal a population of cells enriched for STRO-1bright cells and/or progeny thereof and/or soluble factors derived therefrom.
    Type: Application
    Filed: July 4, 2011
    Publication date: July 4, 2013
    Applicant: MESOBLAST, INC.
    Inventors: Silviu Itescu, Michael David Schuster
  • Publication number: 20130171099
    Abstract: A method for suppressing T cell activation which comprises contacting a cell population comprising T cells in vitro or ex viva with an effective amount of STRO-1+ cells and/or soluble factors derived therefrom to suppress cell activation.
    Type: Application
    Filed: July 4, 2011
    Publication date: July 4, 2013
    Applicant: MESOBLAST, INC.
    Inventors: Silviu Itescu, Michael David Schuster